SHARE

Spain, Accelerator, 2017

Five Spanish start-ups pitch to win €50k in Headstart funding

9th July 2019

A total of 46 proposals were received in the first phase

 

Following a 26 May pitch contest at Barcelona Science Park, five start-ups were selected to receive a total of €50 000 in funding each in the EIT Health Spain Headstart 2017 competition.
When the Headstart 2017 call closed, EIT Health Spain had received a total of 46 proposals, and these were winnowed down to 10 finalists, who participated in the pitch.

The five winners chosen after making their pitchers are:

  • Aelix Therapeutics S.L.: A European cure for HIV Infection.
  • 2Eyes Vision: Technological and clinical validation of the SimVis technology to treat presbyopia with multifocal contact lenses.
  • Rethink Medical: T-Control Urinary Catheter.
  • Avizorex Pharma: A phase I/II proof-of-concept clinical study double-blind, placebo-controlled study assessing the safaty and efficacy of AVX-012 ophthalmic solution in subjetcs with mild to moderate dry eye syndrome.
  • Onalabs Healthcare Inno-Hub: Werable digital device for monitoring chronic patients with cardiac and respiratory diseases

For more information about the call for proposals, please contact clc.spain@eithealth.eu.

EIT Health selecting three Supervisory Board members

EIT Health selecting three Supervisory Board members

Independent members sought; apply by 23 May

Find out more

Bridgehead announces first start-ups for 2021

Bridgehead announces first start-ups for 2021

Helping SMEs expand in Europe and beyond

Find out more

EIT Health rewards societal impact at Pitch Contest

EIT Health rewards societal impact at Pitch Contest

Amparo takes 1st place at MedtecLIVE

Find out more